By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TapImmune Inc. 

2815 Eastlake Avenue East
Suite 300
Seattle  Washington  98102  U.S.A.
Phone: 866-359-7541 Fax: n/a




Company News
TapImmune Inc. (TPIV) Prevails In Legal Dispute With Michael Gardner 7/24/2014 10:53:30 AM
TapImmune Inc. (TPIV) Appoints Leading Immunotherapy Researcher to Chair Scientific Advisory Board 6/13/2014 7:29:08 AM
TapImmune Inc. (TPIV) Is Pleased To Provide An Update On Corporate Events And Milestones For 2014 4/3/2014 9:54:47 AM
TapImmune Inc. (TPIV) Is Pleased To Announce The Filing Of New Intellectual Property Surrounding Its Novel And Proprietary Platform Expression System Polystart™ 3/20/2014 10:12:31 AM
TapImmune Inc. (TPIV) Is Pleased To Announce The Signing Of An Exclusive Option Agreement For A New Phase 1 Clinical Program In Breast And Ovarian Cancer 3/19/2014 9:02:38 AM
TapImmune Inc. (TPIV) Releases Positive Interim Data On Phase I Clinical Trial In HER2/Neu+ Breast Cancer 3/3/2014 9:19:35 AM
TapImmune Inc. (TPIV) Chairman And CEO, Glynn Wilson, Ph.D. Provides Corporate Update On Company Progress 2/27/2014 9:57:52 AM
TapImmune Inc. (TPIV) Announces the Appointment of Sherry Grisewood to the Board of Directors 3/20/2013 9:21:21 AM
TapImmune Inc. (TPIV) to Present at the Florida Road Show Conference on March 14, 2013 3/13/2013 8:48:48 AM
Details of HER-2/Neu Class I Antigen Licensed by TapImmune Inc. (TPIV) Published in Journal of Immunology: Antigen is a Naturally Processed Epitope for Breast Cancer Vaccines 1/22/2013 10:19:55 AM